BBSRC is Major Partner in Europe-wide Synthetic Biology Funding

News   May 14, 2013

 
BBSRC is Major Partner in Europe-wide Synthetic Biology Funding
 
 
 

RELATED ARTICLES

Searching for the CRISPR Swiss-army Knife

News

High-resolution structural comparison of Cpf1 and Cas9 could help researchers achieve more accurate gene editing with CRISPR.

READ MORE

BioGenes Establishes Scientific Advisory Board

News

BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, announces the establishment of a Scientific Advisory Board.

READ MORE

SYGNIS AG Signs Supply Agreement with US Biological for the Lightning-Link Antibody Labelling Technology

News

SYGNIS AG, the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, announced it has signed a supply agreement with US Biological, Salem, MA, USA, for its Innova Lightning-Link® technology.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE